Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Invitrogen, a division of Life Technologies, has launched the Neon transfection device, a tool that enables researchers to better understand the functions of cells, genes and proteins.
Subscribe to our email newsletter
This transfection device simplifies the delivery of DNA, RNA, and proteins into a wide range of mammalian cell types, especially difficult to transfect cells, such as many types of primary and stem cells, the company said.
The Neon transfection device is reported to be the first tool introduced by Invitrogen for transfection of cells, broadening its portfolio of delivery technologies that includes the Lipofectamine brand of reagents.
Transfection is a laboratory technique that enables scientists to deliver foreign molecules into cells that normally do not allow entry of these agents. By performing this technique, researchers are able to manipulate gene activity and cellular protein levels.
Charles Piazza, vice president of Invitrogen molecular biology reagents at Life Technologies, said: “The Neon transfection device expands our extensive portfolio of transfection solutions by enabling scientists to successfully apply this technique to a much greater number of biologically relevant cell types.”